Top Popular News Today
Read more :
Patent's Defeat in India Is Key Victory for Generic Drugs - New York Times
Economic Times Patent’s Defeat in India Is Key Victory for Generic Drugs New York Times NEW DELHI — India’s Supreme Court rejected a patent attention by Novartis for a major cancer drug on Monday, in a landmark ruling that will permit poor patients continued access to many of the world’s best medicines, at least for a while. News Summary: Drugmaker Novartis loses India complaint over patent for cancer … Washington Post Novartis loses landmark India cancer drug patent justification Reuters India Court Ruling Against Novartis Is Dark Omen For Huge Pharma Forbes MarketWatch (blog) - U.S
Reckon it over original article:
Patent’s Defeat in India Is Key Victory for Generic Drugs – New York Times
No comments:
Post a Comment